Dextromethorphan and guaifenesin use must be monitored thoroughly in clients with "weak metabolizer" CYP2D6 enzyme amounts and individuals who are sedated. This mix medication includes a large median toxic dose (TD50) to median efficient dose (ED50) ratio (or therapeutic index) in these individuals. We only use excellent, credible resources to https://chemicalglobe.com/product-tag/dxm-for-sale-near-me/